Skip to content

People Services Industries Insights Our Story

Locations

News Diversity Pro Bono Social Responsibility Sustainability Alumni Careers

Home
Services
IP Litigation

IP Litigation

- Letter
- A4

This is available in:

English
日本語

Sidley Client Amgen Prevails in Precedent-Setting Biologics Patent Dispute

August 14, 2019

Sidley Prevails on Behalf of Bayer in $155 Million Jury Win

February 8, 2019

Sidley Secures Win Against Acacia in Federal Circuit

December 14, 2018

Benchmark Recognizes Sidley

October 20, 2018

Contacts

Jim Badke

Partner

jbadke@sidley.com +1 212 839 7361

New York
Mike Bettinger

Partner

mbettinger@sidley.com +1 415 772 1224

San Francisco
Jeffrey P. Kushan

Partner

jkushan@sidley.com +1 202 736 8914

Washington, D.C.
David T. Pritikin

Partner

dpritikin@sidley.com +1 312 853 7359

Chicago
Thomas D. Rein

Partner

trein@sidley.com +1 312 853 7117

Chicago

View Professionals

Areas of Focus

Cleantech
Copyright and Theft of Idea Litigation
False Advertising Litigation
ITC Section 337
Patent Assessment and Due Diligence
Patent Litigation
Trade Secret and Unfair Competition Litigation
Trademark Litigation

Related Capabilities

SERVICES

Antitrust/Competition
Supreme Court and Appellate
Food, Drug and Medical Device Compliance and Enforcement
Food, Drug and Medical Device Regulatory
Healthcare
Technology and IP Transactions
Global Arbitration, Trade and Advocacy
Privacy and Cybersecurity
Emerging Companies and Venture Capital

INDUSTRIES

Life Sciences

News & Insights

Client Login Attorney Advertising Privacy Policy Terms & Conditions Contact Us Social Media Directory

© 2019 Sidley Austin LLP

Locations

Edition: United States

To learn more about the specific legal services we offer in another region of the world, choose an edition from the selections below.

United States

Europe

China - 中文 China - English

Japan - 日本語 Japan - English

Global

We use cookies on our website. To learn more about cookies, how we use them on our site and how to revise your cookie settings, please view our updated privacy and cookie policy.

You have successfully set your edition to United States. Would you like to make this selection your default edition?

*Selecting a default edition will set a cookie.

We use cookies on our website. To learn more about cookies, how we use them on our site and how to revise your cookie settings, please view our updated privacy and cookie policy.

This page is available in your default region.